Frankfurt - Delayed Quote EUR

Clover Health Investments, Corp. (7QD.F)

3.2450
-0.0720
(-2.17%)
At close: May 9 at 3:29:01 PM GMT+2
Loading Chart for 7QD.F
  • Previous Close 3.3170
  • Open 3.2640
  • Bid 3.0400 x --
  • Ask 3.1730 x --
  • Day's Range 3.2450 - 3.2640
  • 52 Week Range 0.7464 - 4.5500
  • Volume 20
  • Avg. Volume 137
  • Market Cap (intraday) 1.582B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0800
  • Earnings Date Aug 4, 2025 - Aug 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It operates Clover Assistant, a software platform to execute strategy by enabling physicians to detect, identify, and manage chronic diseases earlier than they otherwise could. The company is based in Wilmington, Delaware.

www.cloverhealth.com

570

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 7QD.F

View More

Performance Overview: 7QD.F

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

7QD.F
6.78%
S&P 500 (^GSPC)
3.77%

1-Year Return

7QD.F
315.17%
S&P 500 (^GSPC)
8.55%

3-Year Return

7QD.F
29.39%
S&P 500 (^GSPC)
41.81%

5-Year Return

7QD.F
69.56%
S&P 500 (^GSPC)
93.18%

Compare To: 7QD.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 7QD.F

View More

Valuation Measures

As of 5/8/2025
  • Market Cap

    1.57B

  • Enterprise Value

    1.28B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.34

  • Price/Book (mrq)

    5.56

  • Enterprise Value/Revenue

    1.14

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.69%

  • Return on Assets (ttm)

    -2.47%

  • Return on Equity (ttm)

    -7.75%

  • Revenue (ttm)

    1.49B

  • Net Income Avi to Common (ttm)

    -24.37M

  • Diluted EPS (ttm)

    -0.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    160.1M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    128.38M

Research Analysis: 7QD.F

View More